You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 19, May 18, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Health Policy
 •Law and Medicine
 •Neurology
 •Patient-Physician Relationship/ Care
 •End-of-life Care/ Palliative Medicine
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Perspectives on New Recommendations for Nonoccupational HIV Postexposure Prophylaxis

Roland C. Merchant, MD, MPH; Kenneth H. Mayer, MD

JAMA. 2005;293:2407-2409.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In an important initial step for providing advice to US clinicians on this complex subject, the Centers for Disease Control and Prevention (CDC) recently released national guidelines for provision of human immunodeficiency virus (HIV) nonoccupational postexposure prophylaxis (HIV NPEP).1 In the guidelines, the CDC defines nonoccupational exposure as

any direct mucosal, percutaneous, or intravenous contact with potentially infectious body fluids that occurs outside perinatal or occupational situations (eg, health care, sanitation, public safety, or laboratory employment). Potentially infectious body fluids are blood, semen, vaginal secretions, rectal secretions, breast milk, or other body fluid that is contaminated with visible blood.

These guidelines, which were constructed through a multiyear consultation process, endorse and make recommendations for the use of antiretroviral medications following sexual, injection drug, and other nonoccupational exposures to HIV.

The new CDC guidelines replace a 1998 CDC advisory to clinicians on . . . [Full Text of this Article]

Author Affiliations: Departments of Emergency Medicine (Dr Merchant), Medicine (Dr Mayer), and Community Health (Drs Merchant and Mayer), Brown Medical School, Providence, RI.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Nonoccupational HIV Postexposure Prophylaxis
Geoffrey A. Weinberg, Amneris E. Luque, and Sheldon T. Brown
JAMA. 2005;294(13):1615.
EXTRACT | FULL TEXT  

Nonoccupational HIV Postexposure Prophylaxis—Reply
Kenneth H. Mayer and Roland C. Merchant
JAMA. 2005;294(13):1615-1616.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nonoccupational HIV Postexposure Prophylaxis
Weinberg et al.
JAMA 2005;294:1615-1615.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.